Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy

Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy

PurposeIn this research, we established, for the first time, an immune-inflammatory prognostic score (IIPS) reflecting the balance of immune and inflammatory status to explore its prognostic value in patients with esophageal squamous cell carcinoma (ESCC) receiving neoadjuvant immunochemotherapy (NI...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qiang Zhao, Liang Wang, Xun Yang, Jifeng Feng, Qixun Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	esophageal squamous cell carcinoma immune-inflammatory prognostic score neoadjuvant immunochemotherapy prognosis survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1617681/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
by: Jifeng Feng, et al.
Published: (2024-12-01)

The systemic oxidative stress index predicts clinical outcomes of esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy
by: Jifeng Feng, et al.
Published: (2025-01-01)

Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety
by: Xiaomin Wang, et al.
Published: (2025-04-01)

Circulating Tumor DNA Dynamic Changes in Esophageal Squamous Cell Carcinoma Receiving Immunochemotherapy
by: Yijia Guo, et al.
Published: (2025-05-01)

Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma
by: Qiuying An, et al.
Published: (2025-07-01)

Neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study with 2-year survival analysis
by: Chong-Rui Li, et al.
Published: (2025-07-01)

Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
by: Hai Zhang, et al.
Published: (2025-08-01)

Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis
by: Hui Xu, et al.
Published: (2025-03-01)

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma
by: Gaofeng Ding, et al.
Published: (2025-05-01)

Neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice: an analysis of the clinical outcomes and long-term survival, and the feasibility of using major pathological response as a surrogate endpoint
by: Jiacong Liu, et al.
Published: (2025-04-01)

Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma
by: Gang Li, et al.
Published: (2025-05-01)

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01)

The Lung Cancer Immune Prognostic Score predicts pathologic complete response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy
by: Yuyan Xie, et al.
Published: (2025-04-01)

Predicting pathological response of resectable esophageal squamous cell carcinoma to neoadjuvant anti-PD-1 with chemotherapy using serum inflammation indexes
by: Peng Song, et al.
Published: (2025-07-01)

Prognostic factors in locally advanced oesophageal squamous cell carcinoma: a clinical and radiomic analysis of neoadjuvant immunochemotherapy before surgery
by: Yan Zhu, et al.
Published: (2025-03-01)

Effectiveness and Safety of Neoadjuvant Immunochemotherapy with and without Surgery in Patients with Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study
by: Liao X, et al.
Published: (2025-06-01)

The efficacy of neoadjuvant immunotherapy and lymphocyte subset predictors in locally advanced esophageal squamous cell carcinoma: A retrospective study
by: Ruotong Wang, et al.
Published: (2024-09-01)

Naples Prognostic Score as a Novel Prognostic Prediction Tool for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy
by: Chen W, et al.
Published: (2025-04-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)

Clinical efficacy and biomarkers of neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma
by: Siyou Deng, et al.
Published: (2025-06-01)

Clinical efficacy of different neoadjuvant therapies for resectable esophageal squamous cell carcinoma
by: Xiaoyang Wang, et al.
Published: (2025-06-01)

Case Report: Pathological complete response achieved with neoadjuvant immunochemotherapy in synchronous multiple gastric adenocarcinoma
by: Ya-hui Sun, et al.
Published: (2025-07-01)

Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma
by: Mikako Tamba, et al.
Published: (2025-04-01)

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
by: Yingyi Li, et al.
Published: (2025-02-01)

Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial
by: Jincheng Guo, et al.
Published: (2025-04-01)

Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
by: Canjun Li, et al.
Published: (2025-04-01)

CT-based radiomics for prediction of response to neoadjuvant immunochemotherapy in patients with esophageal carcinoma
by: Peng Zhao, et al.
Published: (2025-05-01)

Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma
by: Likun Liu, et al.
Published: (2025-08-01)

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study
by: Qi Zhao, et al.
Published: (2025-08-01)

Predicting anastomotic leak in patients with esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy using a nomogram based on CT radiomic and clinicopathologic factors
by: Junfeng Zhao, et al.
Published: (2025-03-01)

Homologous recombination deficiency score is an independent prognostic factor in esophageal squamous cell carcinoma
by: Yulu Wang, et al.
Published: (2024-11-01)

Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma
by: Guanzhi Ye, et al.
Published: (2025-04-01)

Impact of neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy on postoperative safety in locally advanced esophageal squamous cell carcinoma: a propensity score-matched retrospective cohort study
by: Yixin Li, et al.
Published: (2025-05-01)

Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB–IIIB non-small-cell lung cancer in real-world practice
by: Yongfeng Shuai, et al.
Published: (2025-07-01)

Identification of biomarkers for tumor regression grade in esophageal squamous cell carcinoma patients after neoadjuvant chemoradiotherapy
by: Zhifu Chen, et al.
Published: (2025-01-01)

Multi‐Institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
by: Fangdong Zhao, et al.
Published: (2025-02-01)

Preoperative albumin-to-fibrinogen ratio as a predictor of postoperative hospital stay in locally advanced esophageal squamous cell carcinoma after neoadjuvant therapy
by: Hao Chen, et al.
Published: (2025-07-01)

The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real−world study
by: Xue Wu, et al.
Published: (2025-05-01)

Tertiary lymphoid structures correlate with the therapeutic efficacy and prognosis of resectable esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy plus immunotherapy
by: Ke Zhai, et al.
Published: (2025-08-01)

Safety and efficacy analysis of neoadjuvant radiotherapy combined with concurrent paclitaxel plus nedaplatin versus other platinum-based chemotherapy for thoracic segmental esophageal squamous cell carcinoma
by: Qingyang Zhuang, et al.
Published: (2025-05-01)